Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States

被引:1
|
作者
Kawano, Yumeko [1 ]
Kolstad, Kathleen D. [2 ]
Li, Shufeng [3 ,4 ]
Simard, Julia F. [5 ,6 ]
Chung, Lorinda [5 ,7 ]
机构
[1] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA
[2] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA
[3] Stanford Univ, Sch Med, Dept Dermatol, Palo Alto, CA 94304 USA
[4] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA
[5] Stanford Univ, Div Immunol & Rheumatol, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA
[6] Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Palo Alto, CA 94304 USA
[7] Palo Alto VA Hlth Care Syst, Div Rheumatol, Palo Alto, CA USA
基金
美国国家卫生研究院;
关键词
Systemic sclerosis; Pregnancy; Preterm birth; Preeclampsia; Outcomes; Epidemiology; AMERICAN-COLLEGE; HYPERTENSION;
D O I
10.1016/j.semarthrit.2023.152252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We sought to examine temporal trends in adverse pregnancy outcomes among SSc pregnancies in a large nationwide sample.Methods: We used the National Inpatient Sample (NIS) database from 2000 - 2017 to derive national estimates of delivery-associated hospitalizations in the United States among patients with SSc. Each SSc delivery was matched to 100 non-SSc deliveries by age, delivery year, and race. We evaluated adverse pregnancy outcomes (APOs) including maternal and fetal death, cesarean delivery, hospital length of stay, preterm delivery, intrauterine growth restriction, and hypertensive disorders of pregnancy. We used multivariable regression models with an interaction term between SSc and year and adjusting for race, advanced maternal age, diabetes mellitus, and pre-existing hypertension to evaluate temporal trends in APOs among SSc and non-SSc deliveries.Results: From 2000 to 2017, there were 3740 delivery-associated hospitalizations for women with SSc. SSc was associated with an increased risk of all APOs compared to non-SSc deliveries. Fetal death declined in SSc de-liveries from 49.0 per 1000 delivery-related admissions in 2000 - 2005 to 16.2 per 1000 in 2012 - 2017. There was a significant difference in trends for fetal death between SSc and non-SSc deliveries (p = 0.043), but the trends for other APOs did not differ between the two groups.Conclusions: In this large nationwide sample, the risk of fetal death among women with SSc markedly improved over the past 18 years. The risk for other APOs remained high in SSc deliveries compared to non-SSc deliveries, and further studies are needed to determine what strategies can improve these outcomes.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Contraceptive Initiation Among Women in the United States: Timing, Methods Used, and Pregnancy Outcomes
    Horwitz, Mara E. Murray
    Ross-Degnan, Dennis
    Pace, Lydia E.
    PEDIATRICS, 2019, 143 (02)
  • [22] Pregnancy in women with systemic sclerosis
    Steen, VD
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (01): : 15 - 20
  • [23] Pregnancy among women with intellectual disabilities in the United States
    Horner-Johnson, W.
    Darney, B.
    Kulkarni-Rajasekhara, S.
    Caughey, A.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2016, 60 (7-8) : 684 - 684
  • [24] Factors associated with adverse pregnancy outcomes in women with systemic lupus erythematosus
    Muto, Haruka
    Kanagawa, Takeshi
    Kanda, Masako
    Inatomi, Ayako
    Kawaguchi, Haruna
    Miyazato, Mai
    Tsuji, Soichiro
    Waguri, Masako
    Wada, Yoshinao
    Ishii, Keisuke
    Mitsuda, Nobuaki
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2016, 118 : 114 - 115
  • [25] Trends in Maternal and Fetal Outcomes Among Pregnant Women With Systemic Lupus Erythematosus in the United States (vol 171, pg 164, 2019)
    Mehta, B.
    Luo, Y.
    Xu, J.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (03) : 432 - 432
  • [26] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Comment
    White, Tacey
    Williams, Amy
    DeSesso, John M.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 124 - 125
  • [27] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Response
    Sweeting, J. Nicole
    Wells, Peter G.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 126 - 127
  • [28] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Response
    Fejzo, Marlena
    MacGibbon, Kimber
    Mullin, Patrick
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 123 - 123
  • [29] Adverse perinatal outcomes among interracial couples in the United States
    Getahun, D
    Ananth, CV
    Selvam, N
    Demissie, K
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (01): : 81 - 88
  • [30] Adverse Neonatal Outcomes Among Women With Hypertensive Disorders of Pregnancy
    Rincon, Monica P.
    Kuo, Kelly
    Sabol, Bethany
    Burwick, Richard
    OBSTETRICS AND GYNECOLOGY, 2017, 129 : 37S - 38S